Pharmacokinetic behavior of intravitreal triamcinolone acetonide prepared by a hospital pharmacy

Japanese Journal of Ophthalmology

Volumn 52, Issue 6, 2008, Pages 489-492

  Oishi, Masako ^a   Maeda, Shinichiro ^a   Hashida, Noriyasu ^b   Ohguro, Nobuyuki ^b   Tano, Yasuo ^b   Kurokawa, Nobuo ^a  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Hospital pharmaceutical preparation; Intravitreal injection; Pharmacokinetics analysis; Sodium hyaluronate; Triamcinolone acetonide

Indexed keywords

DRUG VEHICLE; HYALURONIC ACID; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; DRUG MANUFACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PHARMACY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; VITREOUS BODY;

ANIMALS; COMMERCE; GLUCOCORTICOIDS; HALF-LIFE; INJECTIONS; MALE; MODELS, BIOLOGICAL; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PHARMACIES; PHARMACY SERVICE, HOSPITAL; POWDERS; RATS; RATS, WISTAR; SUSPENSIONS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 57849107300     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-008-0584-0     Document Type: Article

References (26)

1. G.A. Peyman R. Cheema M.D. Conway 2000 Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy Retina 20 554 555
2. J.B. Jonas 2004 Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia Am J Ophthalmol 137 367 368
3. R.F. Degenring J.B. Jonas 2003 Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis Br J Ophthalmol 87 361
4. D.B. Roth J. Chieh M.J. Spirn 2003 Noninfectious endophthalmitis associated with intravitreal triamcinolone injection Arch Ophthalmol 121 1279 1282
5. T. Sakamoto M. Miyazaki T. Hisatomi 2002 Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown Graefes Arch Clin Exp Ophthalmol 240 423 429
6. A. Nishimura A. Kobayashi Y. Segawa 2003 Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter Retina 23 777 779
7. M. Oishi S. Maeda A. Nakamura 2005 Examination of purification methods and development of intravitreal injection of triamcinolone acetonide Jpn J Ophthalmol 49 384 387
8. M.D. Ober G.R. Barile S.R. Tari 2006 Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection Am J Ophthalmol 142 597 600
9. J. Garcia-Arumi A. Boixadera J. Giralt 2005 Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use Br J Ophthalmol 89 1112 1114
10. H. Akaike 1974 A new look at the statistical model identification IEEE Trans Automat Contr 19 716 723
11. J. Ben-Nun D.A. Joyce R.L. Cooper 1989 Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis Invest Ophthalmol Vis Sci 30 1055 1061
12. A. Kane M. Barza J. Baum 1981 Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution Invest Ophthalmol Vis Sci 20 593 597
13. M. Barza A. Kane J. Baum 1983 Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys Invest Ophthalmol Vis Sci 24 1602 1606
14. L. Ficker T.A. Meredith S. Gardner 1990 Cefazolin levels after intravitreal injection. Effects of inflammation and surgery Invest Ophthalmol Vis Sci 31 502 505
15. P.M. Beer S.J. Bakri R.J. Singh 2003 Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 681 686
16. V.L. Morrison H.J. Koh L. Cheng 2006 Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits Retina 26 339 344
17. S. Friedrich Y.L. Cheng B. Saville 1997 Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume Curr Eye Res 16 663 669
18. B.A. Berkowitz R.A. Lukaszew C.M. Mullins 1998 Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity Invest Ophthalmol Vis Sci 39 391 396
19. F. Audren M. Tod P. Massin 2004 Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema Invest Ophthalmol Vis Sci 45 3435 3441
20. J.O. Mason 3rd M.D. Somaiya R.J. Singh 2004 Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes Retina 24 900 904
21. H. Gao X. Qiao R. Gao 2004 Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina Vision Res 44 349 356
22. T.A. Ciulla M.H. Criswell R.P. Danis 2001 Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model Arch Ophthalmol 119 399 404
23. G.J. Jaffe C.H. Yang H. Guo 2000 Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device Invest Ophthalmol Vis Sci 41 3569 3575
24. G.N. Scholes W.J. O'Brien G.W. Abrams 1985 Clearance of triamcinolone from vitreous Arch Ophthalmol 103 1567 1569
25. J.B. Jonas I. Kreissig R. Degenring 2003 Intraocular pressure after intravitreal injection of triamcinolone acetonide Br J Ophthalmol 87 24 27
26. R.J. Wingate P.E. Beaumont 1999 Intravitreal triamcinolone and elevated intraocular pressure Aust N Z J Ophthalmol 27 431 432